Harvard Bioscience, Inc. (OQ:HBIO)

Business Focus: Advanced Medical Equipment & Technology

Apr 09, 2024 09:00 am ET
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of approximately...
Mar 12, 2024 10:30 am ET
Sidoti Events, LLC's Virtual March Small-Cap Conference
NEW YORK, NY / ACCESSWIRE / March 12, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 13-14, 2024. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Mar 11, 2024 08:00 am ET
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both to be...
Mar 07, 2024 07:00 am ET
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31, 2023. Jim Green, Chairman and CEO said, “Our fourth quarter revenue was down a modest 1% compared to the...
Mar 06, 2024 08:30 am ET
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society of Toxicology (SOT) conference from March 11-13, 2024, in Salt Lake City. Complementing an already extensive product...
Feb 27, 2024 05:10 pm ET
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended December 31, 2023 before the market opens on March 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time....
Nov 20, 2023 04:40 pm ET
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced it will be presenting at the Benchmark Company 12th Annual Discovery One-on-One Investor Conference to be held Thursday December 7th, 2023 at the New York Athletic Club in New York City. The...
Nov 09, 2023 04:30 pm ET
Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Southwest IDEAS Investor Conference on Thursday November 16, 2023 at The Statler in Dallas, Texas. Joining...
Nov 07, 2023 07:00 am ET
Harvard Bioscience Announces Third Quarter 2023 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2023. Jim Green, Chairman and CEO said, “Overall, I’m encouraged to see solid year-over-year third quarter revenue...
Nov 06, 2023 04:30 pm ET
Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that it will be showcasing its latest product innovations at the Society for Neuroscience (SfN) conference from November 12-15, 2023, in Washington, D.C. Complementing an already extensive...
Oct 30, 2023 09:00 am ET
Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2023 before the market opens on November 7, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time....
Sep 18, 2023 08:57 am ET
Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research
Harvard Bioscience, Inc. (Nasdaq: HBIO) and Etisense announced today that they have entered into an agreement to offer DECRO®, Etisense’s non-invasive telemetry jacket and associated physiological monitoring software, to a broad range of...
Aug 15, 2023 10:20 am ET
Sidoti Events, LLC’s Virtual August Micro-Cap Conference
NEW YORK, NY / ACCESSWIRE / August 15, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Aug 08, 2023 07:18 am ET
Harvard Bioscience Announces Second Quarter 2023 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2023. Jim Green, Chairman and CEO said, “We are encouraged by the continuation of a strong start to the fiscal year,...
Aug 03, 2023 06:30 pm ET
Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present to investors at the Sidoti August Virtual Investor Conference on August 16, 2023. Joining him will be Jennifer Cote, the...
Jul 27, 2023 06:36 pm ET
Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2023 before the market opens on August 8, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time....
Jun 22, 2023 07:55 am ET
Harvard Bioscience Set to Join Russell 2000® and 3000® Indexes
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced that it is set to join the Russell 2000® and Russell 3000 Indexes, according to preliminary membership information posted to the FTSE Russell website. The addition is expected...
Jun 20, 2023 08:01 am ET
Harvard Bioscience Appoints Jennifer Cote as Chief Financial Officer
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of Jennifer Cote as the Company’s Chief Financial Officer and Treasurer, effective June 19, 2023. Cote joined the Company as Vice President of Global Finance in...
May 02, 2023 05:01 pm ET
Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Micro Cap Virtual Conference taking place on May 10th, 2023. Mr....
Apr 25, 2023 08:01 am ET
Harvard Bioscience Announces First Quarter 2023 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2023. First quarter revenues were $30.0 million, up 4% versus $28.8 million in Q1 ‘22. Reported revenue includes an...
Apr 18, 2023 05:10 pm ET
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the initial order for the Company’s new high-capacity behavioral monitoring system for pre-clinical applications. This initial order, which was placed by one of the Company’s...
Apr 17, 2023 04:45 pm ET
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April 25, 2023, and will hold a conference call to discuss the results at 9:00 a.m. Eastern Time....
Mar 20, 2023 02:00 pm ET
Sidoti's Small-Cap Virtual March Conference
NEW YORK, NY / ACCESSWIRE / March 20, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day March Small-Cap Conference taking place Wednesday and Thursday, March 22-23, 2023. The links can also be found at www.sidoticonference.com/events.
Mar 16, 2023 05:14 pm ET
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the Sidoti Virtual Investor Conference taking place on March 22-23, 2023. Mr....
Mar 16, 2023 09:25 am ET
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one meetings with investors at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21,...
Mar 09, 2023 07:00 am ET
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31, 2022. Our fourth quarter revenues were $28.4 million, down 14% versus the comparable prior year period,...
Feb 28, 2023 04:10 pm ET
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET 
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on March 9, 2023, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time....
Feb 14, 2023 09:30 am ET
Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences
NEW YORK, NY / ACCESSWIRE / February 14, 2023 / Sidoti & Company, LLC announces that its two spring conferences are now open for registration. The March Virtual Small-Cap Conference will take place on Wednesday and Thursday, March 22-23, 2023, and the May Virtual Micro-Cap Conference will be on Wednesday and Thursday, May 10-11, 2023.Sidoti hosts eight virtual investor conferences a year, alternating between small- and micro-cap targeted companies. Companies can host both group pr
Dec 12, 2022 08:30 am ET
Harvard Bioscience Announces CFO Transition
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer and treasurer, effective December 31, 2022. The Company has appointed Jennifer Cote, the Company’s vice...
Nov 08, 2022 04:01 pm ET
Harvard Bioscience Announces Third Quarter 2022 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2022. Jim Green, Chairman and CEO, said, "Impacted by a challenging summer, our third quarter revenues were $26.9...
Nov 02, 2022 05:15 pm ET
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2022 after the market closes on November 8, 2022, and will hold a conference call to discuss the results at 4:30 p.m. Eastern Time....
Aug 03, 2022 10:48 pm ET
Harvard Bioscience Announces Second Quarter 2022 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the second quarter ended June 30, 2022. Jim Green, Chairman and CEO, said, "Our second quarter revenues were essentially flat compared to the prior year...
Jul 26, 2022 04:50 pm ET
Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2022 before the market opens on August 4, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time....
May 04, 2022 07:00 am ET
Harvard Bioscience Announces First Quarter 2022 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the first quarter ended March 31, 2022. Jim Green, Chairman and CEO, said, “Our revenue was up 7% on strength from North American sales despite the...
Apr 26, 2022 09:00 am ET
Harvard Bioscience Introduces SmartStudy™: First of Kind, Next Generation Inhalation System Capability Improves Precision and Drives Growth
Harvard Bioscience, Inc. (Nasdaq: HBIO) has introduced SmartStudy™, an innovative technology feature to its Buxco® Inhalation System aimed at supporting more precise results, cost savings, and improved productivity for preclinical researchers....
Apr 21, 2022 04:05 pm ET
Harvard Bioscience Schedules First Quarter 2022 Earnings Conference Call for May 4, 2022 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2022 before the market opens on May 4, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can...
Mar 08, 2022 07:00 am ET
Harvard Bioscience Announces Fourth Quarter 2021 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the period ended December 31, 2021. Jim Green, Chairman and CEO said, “The positive trends we reported through the first three quarters of 2021 have...
Feb 21, 2022 04:30 pm ET
Harvard Bioscience Schedules Fourth Quarter 2021 Earnings Conference Call for March 8, 2022 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on March 8, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You...
Nov 03, 2021 07:00 am ET
Harvard Bioscience Announces Third Quarter 2021 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the period ended September 30, 2021. Jim Green, Chairman and CEO said, “The positive trends we reported in the first half of 2021 have carried through...
Oct 18, 2021 04:50 pm ET
Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on November 3, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time....
Aug 05, 2021 07:00 am ET
Harvard Bioscience Announces Second Quarter 2021 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and six months ended June 30, 2021. Jim Green, Chairman and CEO said, “Demand for our pre-clinical products remains very strong, with revenue...
Jul 19, 2021 04:45 pm ET
Harvard Bioscience Schedules Second Quarter 2021 Earnings Conference Call for August 5, 2021 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2021 before the market opens on August 5, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can...
May 06, 2021 07:15 am ET
Harvard Bioscience Announces First Quarter 2021 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three months ended March 31, 2021. Jim Green, Chairman and CEO said, “Our first quarter revenue reflects continuation of the sales momentum we saw in...
Apr 19, 2021 04:55 pm ET
Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2021 before the market opens on May 6, 2021, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time. You can...
Mar 10, 2021 07:00 am ET
Harvard Bioscience Announces Fourth Quarter 2020 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three months and year ended December 31, 2020. Jim Green, Chairman and CEO said, “Our fourth quarter demonstrated the benefits of our sales...
Feb 18, 2021 05:24 pm ET
Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2020 before the market opens on March 10, 2021, and will hold a conference call to discuss the results on March 10, 2021 at 8:00 a.m....
Dec 22, 2020 06:05 pm ET
Harvard Bioscience Announces New Credit Facility
Harvard Bioscience, Inc. (Nasdaq: HBIO) (“Harvard Bioscience”) today announced the refinancing of its debt with the closing of a new $65 million credit facility (the “Refinancing”). Proceeds from the new facility will be used to retire existing...
Nov 16, 2020 04:35 pm ET
Harvard Bioscience to attend Benchmark’s 9th Annual Discovery One-on-One Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will participate in The Benchmark Company’s 9th Annual Discovery One-on-One Conference. The virtual event will take place...
Nov 05, 2020 07:00 am ET
Harvard Bioscience Announces Third Quarter 2020 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and nine months ended September 30, 2020. Jim Green, Chairman and CEO said, “Since anticipating academic labs around the world would likely...
Oct 20, 2020 04:45 pm ET
Harvard Bioscience Schedules Third Quarter 2020 Earnings Conference Call for November 5, 2020 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2020 before the market opens on November 5, 2020, and will hold a conference call to discuss the results on November 5, 2020 at 8:00...
Sep 16, 2020 04:30 pm ET
Harvard Bioscience to Present at Singular Research Compelling Values Webinar
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, President and CEO, will present at the Singular Research Compelling Values 2020 Webinar on September 17, 2020 at 2:15  p.m. ET. The presentation will be available online via a...
Aug 05, 2020 07:00 am ET
Harvard Bioscience Announces Second Quarter 2020 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and six months ended June 30, 2020. Jim Green, Chairman and CEO said, “Anticipating academic labs around the world would likely experience...
Jul 20, 2020 08:30 am ET
Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2020 before the market opens on August 5, 2020, and will hold a conference call to discuss the results on August 5, 2020 at 8:00 a.m....
May 26, 2020 05:15 pm ET
Harvard Bioscience, Inc. Issues Letter to Shareholders
Jim Green, Chairman, President & Chief Executive Officer of Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”), today issued a letter to shareholders updating them on the Company’s execution against the key strategic...
May 05, 2020 07:00 am ET
Harvard Bioscience Announces First Quarter 2020 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three months ended March 31, 2020. The Company reported revenue of $23.8 million for the quarter, gross margin of 54.6%, with an operating loss of...
Apr 23, 2020 04:25 pm ET
Harvard Bioscience Schedules First Quarter 2020 Earnings Conference Call for May 5, 2020 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first quarter ended March 31, 2020 before the market opens on May 5, 2020, and will hold a conference call to discuss the results on May 5, 2020 at 8:00 a.m. Eastern...
Apr 06, 2020 04:39 pm ET
Harvard Bioscience Announces Appointment of Susan Steele to Board of Directors
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Susan Steele has been appointed to the Company’s Board of Directors as a Class III director, effective April 6, 2020 and will join the Compensation Committee upon the conclusion of the...
Mar 23, 2020 09:00 am ET
Harvard Bioscience Introduces Next Generation Inhalation System to Aid in the Fight Against COVID-19
Harvard Bioscience, Inc. (Nasdaq: HBIO) has launched an innovative technology – known as Accumulated Inhaled Aerosol (AIA) –  for academic researchers, contract research organizations (CROs) and pharmaceutical companies involved in pre-clinical...
Feb 26, 2020 07:15 am ET
Harvard Bioscience Announces Fourth Quarter 2019 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the three and twelve months ended December 31, 2019.  4th Quarter 2019FY 2019Revenue$31.0 million$116.2 millionOperating Income (GAAP)$1.6 million$0.4...
Feb 11, 2020 05:15 pm ET
Harvard Bioscience Schedules Fourth Quarter 2019 Earnings Conference Call for February 26, 2020 at 8:00 AM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2019 before the market opens on February 26, 2020, and will hold a conference call to discuss the results on February 26, 2020 at 8:00...
Nov 21, 2019 04:45 pm ET
Harvard Bioscience to attend Benchmark’s 8th Annual Discovery One-on-One Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will attend The Benchmark Company’s 8th Annual Discovery One-on-One Conference to be held on December 4, 2019 at the New...
Nov 05, 2019 04:00 pm ET
Harvard Bioscience Announces Third Quarter Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), today announced financial results for the three and nine months ended September 30, 2019. The Company reported revenue of $27.4 million for the third quarter of 2019, with an operating loss...
Nov 01, 2019 08:15 am ET
Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Yash Singh being named Executive Vice President, Cellular & Molecular Technologies on October 31, 2019, the Compensation Committee of the Board of Directors approved...
Oct 31, 2019 05:10 pm ET
Harvard Bioscience Announces Executive Appointment
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Yash Singh has been named Executive Vice President, Cellular & Molecular Technologies, reporting to Chairman, President and CEO, Jim Green.  Singh will lead the newly formed Cellular and...
Oct 22, 2019 06:31 pm ET
Harvard Bioscience Schedules Third Quarter 2019 Earnings Conference Call for November 5 at 4:30 PM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for third quarter ended September 30, 2019 after market close on November 5, 2019 and hold a conference call to discuss the results for the third quarter on November 5,...
Oct 21, 2019 08:45 am ET
Harvard Bioscience Announces Executive Appointment
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Ken Olson has been named Vice President and General Manager, Pre-Clinical Systems (DSI), reporting to Chairman, President and CEO, Jim Green. Olson will lead the Pre-Clinical Systems...
Sep 09, 2019 08:00 am ET
Harvard Bioscience Announces Strategic Action Plan and Financial Targets
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announces its strategic action plan and financial targets for rest of year 2019 through 2021. Key strategic actions and financial targets to position Harvard Bioscience for long-term profitable...
Sep 04, 2019 04:45 pm ET
Harvard Bioscience Elects Alan Edrick to Board of Directors
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that its Board of Directors has elected Alan Edrick to Harvard Bioscience’s Board of Directors, effective September 3, 2019. Bertrand Loy, Lead Independent Director, said “After...
Sep 04, 2019 04:45 pm ET
Harvard Bioscience to Present at Janney Healthcare Conference
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced that Chairman, President and CEO, Jim Green, will be presenting at the Janney Montgomery Scott Healthcare Conference in New York City on September 9, 2019 at 9:05 a.m. EDT. A webcast of the...
Jul 25, 2019 04:00 pm ET
Harvard Bioscience Announces Quarter Ended June 30, 2019 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), today announced financial results for the three and six months ended June 30, 2019. Jim Green, Chairman and CEO said, “Although our performance for the quarter was in the range expected, we...
Jul 19, 2019 04:45 pm ET
Harvard Bioscience Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that in connection with Michael Rossi being named Chief Financial Officer on July 18, 2019, the Compensation Committee of the Board of Directors approved the grant of equity awards to Mr....
Jul 19, 2019 02:04 pm ET
Harvard Bioscience Schedules Second Quarter 2019 Earnings Conference Call for July 25 at 4:30 PM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its quarterly results for the second quarter ended June 30, 2019 after market close on July 25, 2019 and hold a conference call to discuss the results for the second quarter on July 25, 2019 at...
Jul 18, 2019 05:44 pm ET
Harvard Bioscience Names Michael Rossi Chief Financial Officer
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Michael Rossi has been named Chief Financial Officer, effective immediately.  Rossi most recently served as Chief Financial Officer of Laborie Medical Technologies, a global medical...
Jul 08, 2019 07:48 am ET
James Green Named President and CEO of Harvard Bioscience
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that James Green has been named President and Chief Executive Officer of the Company by its Board of Directors, effective immediately. Additionally, Harvard Bioscience’s Board has appointed...
Jun 26, 2019 04:10 pm ET
Harvard Bioscience Subsidiary Data Sciences International Launches Hardware for Expanding Research Capabilities
Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq: HBIO) and the global leader in wireless physiologic monitoring, has launched the Signal Interface for researchers collecting telemetry signals to simultaneously...
May 15, 2019 05:00 pm ET
Harvard Bioscience Subsidiary Data Sciences International Launches Digital Telemetry Implant for Measuring Respiratory Endpoints
Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq: HBIO) and the global leader in wireless physiologic monitoring, will showcase its new PhysioTel™ Digital L11R cardiopulmonary implant at the American Thoracic...
May 02, 2019 04:01 pm ET
Harvard Bioscience Reports First Quarter 2019 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO), or the Company, a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported its financial results for the quarter ended March 31, 2019. “During the...
Apr 23, 2019 05:25 pm ET
Harvard Bioscience Schedules First Quarter 2019 Conference Call for May 2 at 4:30 PM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2019 after market trading hours on Thursday, May 2, 2019. A...
Apr 03, 2019 05:18 pm ET
Harvard Bioscience Subsidiary Data Sciences International Wins Award for Best Achievement of Operational Excellence in Pharmaceuticals & Life Sciences
Data Sciences International (DSI), a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, was awarded “Best Achievement of Operational Excellence...
Mar 26, 2019 05:15 pm ET
Harvard Bioscience To Showcase Products at Experimental Biology 2019
Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting new laboratory products and applications for preclinical life science research at...
Feb 28, 2019 04:02 pm ET
Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported its financial results for the fourth quarter and full year ended December 31,...
Feb 26, 2019 04:30 pm ET
Harvard Bioscience Subsidiary Data Sciences International to Participate at SOT 2019 With Presentation and Exhibit
Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is spotlighting a range of its products and...
Feb 19, 2019 04:05 pm ET
Harvard Bioscience Schedules Fourth Quarter 2018 Conference Call for February 28 at 4:30 PM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its fourth quarter 2018 after market trading hours on Thursday, February 28,...
Nov 23, 2018 07:25 am ET
Report: Exploring Fundamental Drivers Behind Harvard Bioscience, TTM Technologies, BSQUARE, United Therapeutics, KCAP Financial, and Gladstone Capital — New Horizons, Emerging Trends, and Upcoming Dev
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Harvard Bioscience, Inc. (NASDAQ:HBIO), TTM Technologies, Inc....
Nov 02, 2018 02:30 pm ET
Harvard Bioscience Presents Data, Symposium Session and New Products at Neuroscience 2018
Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting its new neuroscience products and applications for preclinical life science research at...
Oct 25, 2018 04:02 pm ET
Harvard Bioscience Reports Third Quarter 2018 Financial Results
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and nine months ended September 30, 2018. “Our...
Oct 22, 2018 04:11 pm ET
Harvard Bioscience Names Kam Unninayar as Chief Financial Officer
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed Kam Unninayar as Chief Financial Officer (CFO), effective November 26, 2018....
Oct 18, 2018 04:30 pm ET
Harvard Bioscience Schedules Third Quarter 2018 Conference Call for October 25 at 4:30 PM ET
Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2018 after market trading hours on Thursday, October 25, 2018....
Aug 22, 2018 08:30 am ET
Harvard Bioscience Announces Management Change
Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today announced the resignation of Robert E. Gagnon, Chief Financial Officer, effective...
Jul 26, 2018 04:01 pm ET
Harvard Bioscience Reports Second Quarter 2018 Financial Results
Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and six months ended June 30, 2018. “I am very...
Jul 19, 2018 09:00 am ET
Harvard Bioscience Schedules Second Quarter 2018 Conference Call for July 26 at 4:30 PM ET
Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2018 after market trading hours on Thursday, July 26, 2018. A...
Jun 20, 2018 04:01 pm ET
Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants For Measuring Continuous Blood Glucose
Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq:HBIO) and the global leader in wireless physiologic monitoring, launched two telemetry implants, the PhysioTel™ Digital M0G and M1G, to meet the changing needs of...
Jun 13, 2018 04:01 pm ET
Harvard Bioscience Subsidiary Data Sciences International Launches Inhalation Exposure System
Data Sciences International (DSI), a subsidiary of Harvard Bioscience, Inc. (Nasdaq:HBIO) launched a new inhalation and exposure system to meet the evolving needs of researchers. The DSI Buxco Inhalation Exposure System is designed with the...
May 02, 2018 04:01 pm ET
Harvard Bioscience Reports First Quarter 2018 Financial Results
Harvard Bioscience, Inc. (Nasdaq:HBIO), or the Company, a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported its financial results for the quarter ended March 31, 2018. “We are excited...
May 01, 2018 05:00 pm ET
Harvard Bioscience Subsidiary Multi Channel Systems Launches Beta Cell Screening System for Diabetes Research, Entering New Segment of Electrophysiology Market
Multi-Electrode Array (MEA) Offers New Route for Type 2 Diabetes Drug Development and Ability to Elucidate Beta Cell Pathophysiology
May 01, 2018 04:30 pm ET
Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants to Enhance Neuroscience Research
PhysioTel™ Digital L03 and L04 Designed to Improve Animal Welfare in Large Animal Models
Apr 23, 2018 04:05 pm ET
Harvard Bioscience Schedules First Quarter 2018 Conference Call for May 2 at 4:30 PM ET
HOLLISTON, Mass., April 23, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2018 after market...
Mar 01, 2018 04:01 pm ET
Harvard Bioscience Reports Fourth Quarter and Year-End 2017 Results
Third Consecutive Quarter of Top Line Organic Growth and DSI Acquisition Position Company for Further Improvements in 2018
Feb 22, 2018 04:45 pm ET
Harvard Bioscience Schedules Fourth Quarter 2017 Conference Call for March 1 at 4:30 PM ET
HOLLISTON, Mass., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its fourth quarter 2017 after market...
Jan 31, 2018 06:45 pm ET
Harvard Bioscience Completes Acquisition of Data Sciences International
HOLLISTON, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that the Company has completed the...
Oct 26, 2017 04:01 pm ET
Harvard Bioscience Reports Third Quarter 2017 Financial Results
HOLLISTON, Mass., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and nine months ended September 30, 2017....
Oct 25, 2017 04:30 pm ET
Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors
HOLLISTON, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, appointed Katherine Eade and Thomas Loewald as Class II directors of the Board of Directors, effective as of October 24, 2017. ...
Jul 27, 2017 04:02 pm ET
Harvard Bioscience Reports Second Quarter 2017 Financial Results
HOLLISTON, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and six months ended June 30, 2017....
Jul 18, 2017 05:15 pm ET
Harvard Bioscience Schedules Second Quarter 2017 Conference Call for July 27 at 4:30 PM ET
HOLLISTON, Mass., July 18, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2017 after market trading hours on Thursday, July 27, 2017. A conference call to discuss the company's second quarter 2017 financial results and its operations is scheduled for that same date at 4:30 PM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, includi...
Jun 07, 2017 04:05 pm ET
Harvard Bioscience Elects James Green as Chairman of Board of Directors
HOLLISTON, Mass., June 07, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, has elected James Green, a current Board member, as the new Chairman of its Board of Directors effective June 5, 2017.  Earl R. Lewis has served as Chairman since July 2013 and has been a member of the Board since 2000....
Apr 27, 2017 04:01 pm ET
Harvard Bioscience Reports First Quarter 2017 Financial Results
HOLLISTON, Mass., April 27, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today reported its financial results for the quarter ended March 31, 2017....
Apr 19, 2017 04:05 pm ET
Harvard Bioscience Schedules First Quarter 2017 Conference Call for April 27 at 4:30 PM ET
HOLLISTON, Mass., April 19, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2017 after market trading hours on Thursday, April 27, 2017. A conference call to discuss the company's first quarter 2017 financial results and its operations is scheduled for that same date at 4:30 PM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, includi...
Mar 09, 2017 04:01 pm ET
Harvard Bioscience Reports Fourth Quarter and Year-End 2016 Results and 2017 Financial Guidance
HOLLISTON, Mass., March 09, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported its financial results for the fourth quarter and full year ended December 31, 2016....
Feb 23, 2017 04:30 pm ET
Harvard Bioscience Schedules Fourth Quarter 2016 Conference Call for March 9 at 4:30 PM ET
HOLLISTON, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its fourth quarter 2016 after market trading hours on Thursday, March 9, 2017. A conference call to discuss the company's fourth quarter 2016 financial results and its operations is scheduled for that same date at 4:30 PM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, inclu...
Oct 27, 2016 04:01 pm ET
Harvard Bioscience Reports Third Quarter 2016 Financial Results
HOLLISTON, Mass., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and nine months ended September 30, 2016. The company also announced the disposition of its AHN Biotechnologie GmbH (AHN) subsidiary for $1.7 million....
Oct 13, 2016 04:15 pm ET
Harvard Bioscience Schedules Third Quarter 2016 Conference Call for October 27 at 4:30 PM ET
HOLLISTON, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2016 after market trading hours on Thursday, October 27, 2016. A conference call to discuss the company's third quarter 2016 financial results and its operations is scheduled for that same date at 4:30 PM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, includ...
Jul 28, 2016 06:15 am ET
Harvard Bioscience Reports Second Quarter 2016 Financial Results
HOLLISTON, Mass., July 28, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported financial results for the three and six months ended June 30, 2016....
Jul 18, 2016 04:30 pm ET
Harvard Bioscience Schedules Second Quarter 2016 Conference Call for July 28 at 8:30 AM ET
HOLLISTON, Mass., July 18, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2016 before market trading hours on Thursday, July 28, 2016. A conference call to discuss the company's second quarter 2016 financial results and its operations is scheduled for that same date at 8:30 AM ET. On that call, management may respond to questions from the audience and provide information on any of a number of topics related to the business, in...
May 12, 2016 06:00 am ET
Harvard Bioscience Reports First Quarter 2016 Financial Results
HOLLISTON, Mass., May 12, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported its financial results for the three months ended March 31, 2016....
May 04, 2016 04:15 pm ET
Harvard Bioscience Regains Compliance with NASDAQ’s Continued Listing Requirements
HOLLISTON, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that it received written notification from NASDAQ (the “Notice”) stating the Company has regained compliance with NASDAQ’s Listing Rule 5250(c)(1) and the matter is now closed.  ...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.